VTVT icon

vTv Therapeutics
VTVT

Overview Fund Activity

24 hedge funds and large institutions have $3.76M invested in vTv Therapeutics in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
-5
Holders Change %
-17.24%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
1
Reduced
10
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
IC
1
Ikarian Capital
Texas
$536K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$17K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$8K
4
TRCT
4
Tower Research Capital (TRC)
New York
$6K

Top Sellers

1
EC
1
EcoR1 Capital
California
$0
2
Morgan Stanley
2
Morgan Stanley
New York
$25K
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
VF
4
Virtu Financial
New York
$0
5
Rafferty Asset Management
5
Rafferty Asset Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Citadel Advisors
26
Citadel Advisors
Florida
– -$94K -2,353 Closed
Rafferty Asset Management
27
Rafferty Asset Management
New York
– -$69K -1,727 Closed
Bank of America
28
Bank of America
North Carolina
– -$22K -556 Closed
ECM
29
ExodusPoint Capital Management
New York
– -$22K -553 Closed
UBS Group
30
UBS Group
Switzerland
– -$17K -422 Closed
Jane Street
31
Jane Street
New York
– -$14K -349 Closed
1
2